Suchergebnisse - "Ulas, Turgay"

PubPharm (122)

1

Real-world data on the effectiveness and safety of Ixazomib-Lenalidomide-Dexamethasone therapy in relapsed/refractory multiple myeloma patients : a multicenter experience in Turkey

enthalten in: Journal of chemotherapy (Florence, Italy) | 2023

von Bakırtaş, M. | Dal, M. | Yiğenoğlu, T. | +17

2

Can orbital artery resistive indexes detect complications of diabetes in the prediabetic phase?

enthalten in: Wiener klinische Wochenschrift | 2023

von Sirkeci, O. | Erkus Sirkeci, E. | Ergün Süzer, N. | +3

3

Can orbital artery resistive indexes detect complications of diabetes in the prediabetic phase?

enthalten in: Wiener klinische Wochenschrift | 2023

von Sirkeci, O. | Erkus Sirkeci, E. | Ergün Süzer, N. | +3

4

Can orbital artery resistive indexes detect complications of diabetes in the prediabetic phase?

enthalten in: Wiener klinische Wochenschrift | 2023

von Sirkeci, O. | Erkus Sirkeci, E. | Ergün Süzer, N. | +3

5

Can orbital artery resistive indexes detect complications of diabetes in the prediabetic phase?

enthalten in: Wiener klinische Wochenschrift | 2023

von Sirkeci, O. | Erkus Sirkeci, E. | Ergün Süzer, N. | +3

6

International Forum : The Turkish perspective on apheresis activity: The Turkish apheresis registry report

enthalten in: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis | 2023

von Ozatli, D. | Giden, A. | Erkurt, M. | +44

7

Gene therapy approaches for sickle cell anemia

enthalten in: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis | 2023

von Ulas, T. | Dal, M.

8

Polatuzumab vedotin, rituximab, and bendamustine combination in relapsed or refractory diffuse large B-cell lymphoma : a real-world data from Turkey

enthalten in: Annals of hematology | 2023

von Dal, M. | Ulu, B. | Uzay, A. | +17

9

Polatuzumab vedotin, rituximab, and bendamustine combination in relapsed or refractory diffuse large B-cell lymphoma: a real-world data from Turkey

enthalten in: Annals of hematology | 2022

von Dal, M. | Ulu, B. | Uzay, A. | +17

10

Polatuzumab vedotin, rituximab, and bendamustine combination in relapsed or refractory diffuse large B-cell lymphoma: a real-world data from Turkey

enthalten in: Annals of hematology | 2022

von Dal, M. | Ulu, B. | Uzay, A. | +17

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[13]